A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma.
Translational cancer research(2023)
摘要
The findings suggest that reduced MYO6 expression levels are associated with disease progression, poor prognosis, and immune cell infiltration, and can be considered as a promising prognostic biomarker for ccRCC.
更多查看译文
关键词
Myosin 6 (MYO6), clear cell renal cell carcinoma (ccRCC), diagnostic, prognosis, immune infiltration
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要